Penserra Capital Management LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$19,578,000
+285.4%
90,267
+105.0%
0.36%
+201.7%
Q4 2020$5,080,000
+140.2%
44,030
+102.5%
0.12%
+50.0%
Q3 2020$2,115,000
+38.6%
21,738
+74.8%
0.08%
+1.3%
Q2 2020$1,526,000
+55.6%
12,437
+10.9%
0.08%
+17.9%
Q1 2020$981,000
+99.0%
11,214
+162.5%
0.07%
+109.4%
Q4 2019$493,000
+82.6%
4,272
+81.6%
0.03%
+39.1%
Q3 2019$270,0002,3520.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders